×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 3: Challenges and Opportunities Case Studies
Session Chair(s)
Tamei Elliott, MS
Associate Director, Scientific Programs
DIA, United States
Case Study 1: Oncology—The Promise of CAR T Therapies: Changing the Way We Treat Cancer
Case Study 2: Accelerating Clinical Development: The Role of Biomarkers in the Development of Gene Therapies
Case Study 3: Lessons Learned from the Clinical Testing of Cell Therapies for Type 1 Diabetes
Case Study 4: San Raffaele Telethon Institute for Gene Therapy
Speaker(s)
Case Study 1: Oncology—The Promise of CAR T Therapies: Changing the Way We Treat Cancer
Representative Invited
Kite Pharma (Gilead), United States
Case Study 2: Accelerating Clinical Development: The Role of Biomarkers in the Development of Gene Therapies
Representative Invited
Celerion, United States
Case Study 3: Lessons Learned from the Clinical Testing of Cell Therapies for Type 1 Diabetes
Doug Melton, PhD
Vertex, United States
Distinguished Research Fellow
Case Study 4: San Raffaele Telethon Institute for Gene Therapy
Alessandro Aiuti
San Raffaele Hospital, Italy
Clinical Research Coordinator and Head of Unit
Have an account?